Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Uveitis Treatment Market, by Drug Class
1.4.2 Europe Uveitis Treatment Market, by Disease Type
1.4.3 Europe Uveitis Treatment Market, by Distribution Channel
1.4.4 Europe Uveitis Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Uveitis Treatment Market by Drug Class
3.1 Europe Anti-inflammatory Market by Country
3.2 Europe Immunotherapy & Targeted Therapies Market by Country
3.3 Europe Antimicrobial Drugs Market by Country
3.4 Europe Other Drug Class Market by Country
Chapter 4. Europe Uveitis Treatment Market by Disease Type
4.1 Europe Anterior Uveitis Market by Country
4.2 Europe Posterior Uveitis Market by Country
4.3 Europe Intermediate Uveitis Market by Country
4.4 Europe Other Diseases Market by Country
Chapter 5. Europe Uveitis Treatment Market by Distribution Channel
5.1 Europe Hospital Pharmacies Market by Country
5.2 Europe Retail Pharmacies Market by Country
5.3 Europe Online stores Market by Country
Chapter 6. Europe Uveitis Treatment Market by Country
6.1 Germany Uveitis Treatment Market
6.1.1 Germany Uveitis Treatment Market by Drug Class
6.1.2 Germany Uveitis Treatment Market by Disease Type
6.1.3 Germany Uveitis Treatment Market by Distribution Channel
6.2 UK Uveitis Treatment Market
6.2.1 UK Uveitis Treatment Market by Drug Class
6.2.2 UK Uveitis Treatment Market by Disease Type
6.2.3 UK Uveitis Treatment Market by Distribution Channel
6.3 France Uveitis Treatment Market
6.3.1 France Uveitis Treatment Market by Drug Class
6.3.2 France Uveitis Treatment Market by Disease Type
6.3.3 France Uveitis Treatment Market by Distribution Channel
6.4 Russia Uveitis Treatment Market
6.4.1 Russia Uveitis Treatment Market by Drug Class
6.4.2 Russia Uveitis Treatment Market by Disease Type
6.4.3 Russia Uveitis Treatment Market by Distribution Channel
6.5 Spain Uveitis Treatment Market
6.5.1 Spain Uveitis Treatment Market by Drug Class
6.5.2 Spain Uveitis Treatment Market by Disease Type
6.5.3 Spain Uveitis Treatment Market by Distribution Channel
6.6 Italy Uveitis Treatment Market
6.6.1 Italy Uveitis Treatment Market by Drug Class
6.6.2 Italy Uveitis Treatment Market by Disease Type
6.6.3 Italy Uveitis Treatment Market by Distribution Channel
6.7 Rest of Europe Uveitis Treatment Market
6.7.1 Rest of Europe Uveitis Treatment Market by Drug Class
6.7.2 Rest of Europe Uveitis Treatment Market by Disease Type
6.7.3 Rest of Europe Uveitis Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 AbbVie, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals:
7.2 Alimera Sciences, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Product Launches and Product Expansions:
7.3 Enzo Biochem, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Amgen, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Research & Development Expense
7.4.4 Recent strategies and developments:
7.4.4.1 Product Launches and Product Expansions:
7.4.4.2 Partnerships, Collaborations, and Agreements:
7.5 Bausch Health Companies, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.6 Clearside Biomedical, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Research & Development Expense
7.6.4 Recent strategies and developments:
7.6.4.1 Partnerships, Collaborations, and Agreements:
7.7 EyePoint Pharmaceuticals, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.7.5.2 Acquisition and Mergers:
7.8 Santen Pharmaceutical Co., Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations, and Agreements:
7.9 Topivert Ltd.
7.9.1 Company Overview
7.1 Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Recent strategies and developments:
7.10.4.1 Acquisition and Mergers:
7.10.4.2 Approvals:
7.10.5 Research & Development Expense
Unique Offerings 